Yüklüyor......
Immune checkpoint inhibitors in clinical trials
Immunology-based therapy is rapidly developing into an effective treatment option for a surprising range of cancers. We have learned over the last decade that powerful immunologic effector cells may be blocked by inhibitory regulatory pathways controlled by specific molecules often called “immune ch...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Sun Yat-sen University Cancer Center
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4190433/ https://ncbi.nlm.nih.gov/pubmed/25189716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.014.10122 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|